Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
French Company Carmat Announces First Implant of Its Artificial Heart in a Woman
Error: Contact form not found.
by Reuters and Algemeiner Staff
Chief Executive Officer of French artificial heart manufacturer Carmat, Stephane Piat, poses holding an artificial heart during an interview with Reuters in Velizy, near Paris, January 11, 2021. Photo: REUTERS/Christian Hartmann/Files
French artificial heartmaker Carmat announced on Tuesday that it had carried out the first implant of its Aeson artificial heart in a woman.
The company said the procedure had been performed at the UofL Health – Jewish Hospital by University of Louisville physicians in the United States.
“This third implant in the US was a landmark event not only because it allowed us to finalize the enrollment of the first cohort of patients of the EFS (early feasibility study), but very importantly because it is the first time ever that our device has helped a woman suffering from heart failure,” Carmat CEO Stephane Piat said in a statement.
